A. Muzikansky

发表

Neuropsychological measures in normal individuals that predict subsequent cognitive decline.

M. Albert, D. Blacker, R. Tanzi, 2007, Archives of neurology.

Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.

Eric E. Smith, M. Albert, R. Killiany, 2008, Archives of neurology.

Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer’s disease

Brian J. Bacskai, Alona Muzikansky, Alberto Serrano-Pozo, 2020, Nature Communications.

Isolation of rare circulating tumour cells in cancer patients by microchip technology

S. Digumarthy, R. Tompkins, D. Haber, 2007, Nature.

Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma.

N. Holalkere, D. Sahani, A. Zhu, 2008, The oncologist.

Correction to: Septal bowing and pulmonary artery diameter on computed tomography pulmonary angiography are associated with short-term outcomes in patients with acute pulmonary embolism

M. Kalra, A. Muzikansky, M. Lev, 2019, Emergency Radiology.

Detection of mutations in EGFR in circulating lung-cancer cells.

Mehmet Toner, Alona Muzikansky, Daniel Irimia, 2008, The New England journal of medicine.

The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas.

Alona Muzikansky, Arnab Chakravarti, Peter M Black, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Investigating documentation of alcohol and non-medical substance use in oncology treatment: an electronic health record review

J. Temel, J. Ostroff, A. Muzikansky, 2022, Supportive Care in Cancer.

Cost Analysis of a Randomized Trial of Early Palliative Care in Patients with Metastatic Nonsmall-Cell Lung Cancer.

Ravi B. Parikh, J. Temel, R. Parikh, 2016, Journal of palliative medicine.

Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors

J. Doroshow, A. Chen, G. Shapiro, 2020, Cancer Chemotherapy and Pharmacology.

Clinical factors associated with massive pulmonary embolism and PE-related adverse clinical events

A. Muzikansky, C. Kabrhel, P. Hariharan, 2021, International Journal of Cardiology.

Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer.

Alona Muzikansky, Colleen Lawrence, Jeffrey W. Clark, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Delineating nonmelanoma skin cancer margins using terahertz and optical imaging

Cecil S. Joseph, Robert H. Giles, Anna N. Yaroslavsky, 2017 .

Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data

C. Gerloff, D. Blacker, C. Anderson, 2020, The Lancet.

A Phase 2 Study of Capmatinib in Patients With MET-Altered Lung Cancer Previously Treated With a MET Inhibitor.

S. Digumarthy, L. Sequist, A. Shaw, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Outcome of patients with de novo versus nevus-associated melanoma.

William M. Lin, A. Sober, A. Muzikansky, 2015, Journal of the American Academy of Dermatology.

Multimodal quantitative imaging of brain cancer in cultured cells.

Michael R Hamblin, M. Hamblin, A. Muzikansky, 2019, Biomedical optics express.

Intraductal papillary mucinous neoplasms: does a family history of pancreatic cancer matter?

M. Mino‐Kenudson, J. Wargo, D. Nehra, 2012, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Differential UBE2C and HOXA1 expression in melanocytic nevi and melanoma

K. Scott, S. Kraft, A. Muzikansky, 2017, Journal of cutaneous pathology.

Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice.

S. Digumarthy, A. Iafrate, C. Channick, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

The Combination of Adenoviral HSV TK Gene Therapy and Radiation is Effective in Athymic Mouse Glioblastoma Xenografts without Increasing Toxic Side Effects

H. Wakimoto, A. Stemmer-Rachamimov, A. Chakravarti, 2004, Journal of Neuro-Oncology.

Clinical significance of microscopic melanoma metastases in the nonhottest sentinel lymph nodes.

A. Sober, A. Muzikansky, A. Cosimi, 2015, JAMA surgery.

REiNS: Reliability of Handheld Dynamometry to Measure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2.

Michael Fisher, A. Muzikansky, D. Stevenson, 2021, Neurology.

Reliability of HandheldDynamometry toMeasure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2

Michael Fisher, A. Muzikansky, D. Stevenson, 2022 .

Chemotherapy with erlotinib or chemotherapy alone in advanced NSCLC with acquired resistance to EGFR tyrosine kinase inhibitors (TKI).

S. Digumarthy, L. Sequist, D. Jackman, 2012 .

Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma.

D. Finkelstein, A. Muzikansky, S. Thayer, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Temperature induced changes in the optical properties of skin in vivo

A. Muzikansky, A. Yaroslavsky, Peter R. Jermain, 2021, Scientific reports.

Predictors Of Treatment Failure After Radiofrequency Ablation For Intramucosal Adenocarcinoma in Barrett Esophagus: A Multi-institutional Retrospective Cohort Study

C. Lightdale, A. Muzikansky, R. Odze, 2016, The American journal of surgical pathology.

A pilot mixed‐methods randomized controlled trial of verbal versus electronic screening for adverse social determinants of health

A. Muzikansky, M. Samuels-Kalow, Wendy L. Macias-Konstantopoulos, 2022, Journal of the American College of Emergency Physicians open.

Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults.

P. Wen, K. Ligon, P. Black, 2008, Neuro-oncology.

Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia

Yuehua Wu, A. Muzikansky, A. Fathi, 2013, Modern Pathology.

Incidence and risk factors of persistent air leak after major pulmonary resection and use of chemical pleurodesis.

J. Wain, D. Mathisen, A. Muzikansky, 2010, The Annals of thoracic surgery.

Palliative Care Study

J. Temel, T. Lynch, A. Muzikansky, 2010 .

Electronic prompt to improve outpatient code status documentation for patients with advanced lung cancer.

J. Temel, A. Muzikansky, E. Park, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of ponatinib in patients with bevacizumab-refractory glioblastoma.

R. Beroukhim, P. Wen, E. Lee, 2018 .

Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer

Manish B. Patel, A. Iafrate, A. Drilon, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors.

Jeffrey W. Clark, C. Fuchs, P. Enzinger, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer.

M. Kris, V. Rusch, C. Azzoli, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cytokeratin 19 Is a Powerful Predictor of Survival in Pancreatic Endocrine Tumors

V. Deshpande, A. Muzikansky, C. Fernández‐del Castillo, 2004, The American journal of surgical pathology.

Phase 1/2 study of everolimus in advanced hepatocellular carcinoma

Jeffrey W. Clark, A. Iafrate, J. Meyerhardt, 2011, Cancer.

Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer.

C. Earle, J. Meyerhardt, P. Fidias, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical outcomes of late rather than early full-donor chimerism in patients with advanced lymphomas receiving nonmyeloablative allogeneic hematopoietic SCT

S. Saidman, D. Ting, A. Muzikansky, 2008, Bone Marrow Transplantation.

ergistic Enhancement of Carboplatin Efficacy with todynamic Therapy in a Three-Dimensional Model for R rometastatic Ovarian Cancer

Adnan O. Abu-Yousif, Rizvi, T. Hasan, 2010 .

Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastoma.

P. Wen, K. Ligon, E. Wong, 2010, International journal of radiation oncology, biology, physics.

Septal bowing and pulmonary artery diameter on computed tomography pulmonary angiography are associated with short-term outcomes in patients with acute pulmonary embolism

M. Kalra, A. Muzikansky, M. Lev, 2019, Emergency Radiology.

Randomized Phase II Study of 3 Months or 2 Years of Adjuvant Afatinib in Patients With Surgically Resected Stage I-III EGFR-Mutant Non–Small-Cell Lung Cancer

M. Kris, C. Azzoli, J. Shrager, 2021, JCO precision oncology.

Examining the effects of stress and psychological distress on smoking abstinence in cancer patients

Daniel L Hall, Daniel L. Hall, N. Rigotti, 2021, Preventive medicine reports.

Role of F-Fluorodeoxyglucose Positron Emission Tomography in Predicting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer

A. Muzikansky, A., H., 2011 .

Brief Report of Biweekly Pemetrexed and Gemcitabine in Elderly Patients with Non-small Cell Lung Cancer

L. Sequist, P. Fidias, R. Heist, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations.

Alona Muzikansky, Thomas J Lynch, Bruce E Johnson, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features.

A. Iafrate, L. Chirieac, J. Beheshti, 2007, The Journal of molecular diagnostics : JMD.

A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy.

Katrina H. Smith, P. Wen, E. Wong, 2014, Neuro-oncology.

Bevacizumab Treatment for Meningiomas in NF2: A Retrospective Analysis of 15 Patients

A. Stemmer-Rachamimov, A. Muzikansky, S. Plotkin, 2013, PloS one.

Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis.

P. D. Dal Cin, H. Kantarjian, A. Muzikansky, 2007, American journal of clinical pathology.

Anatomic and Metabolic Evaluation of Peripheral Nerve Sheath Tumors in Patients With Neurofibromatosis 1 Using Whole-Body MRI and 18F-FDG PET Fusion

G. Harris, A. Muzikansky, M. Bredella, 2014, Clinical nuclear medicine.

Relationship between whole‐body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis

W. Cai, G. Harris, A. Muzikansky, 2014, American journal of medical genetics. Part A.

Angiotropism in primary cutaneous melanoma is associated with disease progression and distant metastases: A retrospective study of 179 cases

S. Kraft, A. Muzikansky, L. Duncan, 2019, Journal of cutaneous pathology.

Gene therapy with apoptosis-associated speck-like protein (ASC), a newly described schwannoma tumor suppressor, inhibits schwannoma growth in vivo.

A. Stemmer-Rachamimov, G. Fulci, M. Giovannini, 2019, Neuro-oncology.

Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics.

M. Mino‐Kenudson, D. Finkelstein, C. Bassi, 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Early palliative care for patients with metastatic non-small-cell lung cancer.

Alona Muzikansky, Craig D Blinderman, Thomas J Lynch, 2010, The New England journal of medicine.

Reply to I.B. Tan et al

J. Temel, A. Muzikansky, J. Greer, 2012 .

The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma

A. Muzikansky, J. Pierie, W. Faquin, 2002, Annals of Surgical Oncology.

Impact of Age on Outcomes with Immunotherapy in Patients with Non–Small Cell Lung Cancer

A. Muzikansky, R. Nipp, J. Gainor, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices [Smokefree Support Study 2.0]

D. Levy, I. Gareen, J. Sicks, 2022, BMC Public Health.

The SELECT study: A multicenter phase II trial of adjuvant erlotinib in resected epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC).

C. Azzoli, P. Jänne, R. Govindan, 2012 .

Long-term toxicity of bevacizumab therapy in neurofibromatosis 2 patients

A. Muzikansky, S. Plotkin, Sanjeev A. Francis, 2014, Cancer Chemotherapy and Pharmacology.

Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas.

L. Fayad, R. Jain, M. Jacobs, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Retrospective study of pemetrexed as salvage therapy for central nervous system lymphoma

P. Wen, S. Kesari, A. Norden, 2013, Journal of Neuro-Oncology.

Edinburgh Research Explorer Opposing Roles of apolipoprotein E in aging and neurodegeneration

B. Hyman, T. Spires-Jones, K. Kuchibhotla, 2019 .

Biologically relevant 3D tumor arrays: treatment response and the importance of stromal partners

Brian W. Pogue, Tayyaba Hasan, Conor L. Evans, 2011, BiOS.

Cost-effectiveness of Implementing Smoking Cessation Interventions for Patients With Cancer

N. Rigotti, D. Levy, J. Ostroff, 2022, JAMA network open.

Isolation of intact extracellular vesicles from cryopreserved samples

M. Toner, S. Stott, A. Muzikansky, 2021, PloS one.

Preliminary results from a multicenter, phase II, randomized, noncomparative clinical trial of radiation and temozolomide with or without vandetanib in newly diagnosed glioblastoma (GBM).

T. Mikkelsen, R. Beroukhim, P. Wen, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase 2 Study of Lorlatinib in Patients With ROS1-Rearranged Lung Cancer With Brain-Only Progression on Crizotinib

A. Shaw, R. Heist, A. Muzikansky, 2022, JTO clinical and research reports.

Histopathologic Prognostic Factors in Stage I Leiomyosarcoma of the Uterus: A Detailed Analysis of 27 Cases

P. Branton, E. Oliva, Wei-Lien Wang, 2011, American Journal of Surgical Pathology.

Low Histologic Grade Follicular Lymphoma With High Proliferation Index: Morphologic and Clinical Features

N. Harris, A. Muzikansky, Lan Wang, 2005, The American journal of surgical pathology.

Clinicopathologic Characteristics and Outcomes for Patients With KRAS G12D-Mutant NSCLC

M. Mino‐Kenudson, L. Sequist, R. Heist, 2022, JTO clinical and research reports.

Bone marrow findings correlate with clinical outcome in systemic AL amyloidosis patients

A. Muzikansky, P. Hawkins, H. Lachmann, 2007, Histopathology.

SELECT: A multicenter phase II trial of adjuvant erlotinib in resected early-stage EGFR mutation-positive NSCLC.

M. Kris, C. Azzoli, P. Jänne, 2014 .

An immunohistochemical comparison of cytokeratin 7, cytokeratin 15, cytokeratin 19, CAM 5.2, carcinoembryonic antigen, and nestin in differentiating porocarcinoma from squamous cell carcinoma.

M. Mahalingam, A. Muzikansky, M. Selim, 2012, Human pathology.

Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma.

B. Korf, G. Cutter, A. Muzikansky, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcomes and patterns of care in adult skull base chondrosarcomas from the SEER database

W. Curry, H. Shih, A. Muzikansky, 2014, Journal of Clinical Neuroscience.

Thoracic radiation therapy in locally advanced NSCLC patients (pts) with EGFR mutations.

R. Mak, L. Sequist, N. Choi, 2010 .

Phase II Study of Lorlatinib in Patients With Anaplastic Lymphoma Kinase–Positive Lung Cancer and CNS-Specific Relapse

S. Digumarthy, A. Shaw, R. Heist, 2022, JCO precision oncology.

Patients With Serious Mental Illness Can Engage in Tobacco Treatment Trials and Tobacco Cessation Interventions During Cancer Treatment

N. Rigotti, J. Ostroff, A. Muzikansky, 2022, JCO oncology practice.

Postoperative intensive care unit requirements after elective craniotomy.

B. Nahed, W. Curry, B. Walcott, 2014, World neurosurgery.

Role of 18 F-Fluorodeoxyglucose Positron Emission Tomography in Predicting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer

R., A. Muzikansky, A., 2011 .

Phase II study of dose-intense temozolomide in recurrent glioblastoma.

R. Beroukhim, P. Wen, A. Norden, 2011, Journal of Clinical Oncology.

Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer.

R. Heist, J. Temel, A. Muzikansky, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Soluble oligomeric amyloid-β induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain

Josiah R. Boivin, B. Hyman, B. Bacskai, 2017, Molecular Neurodegeneration.

Thal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum

T. Montine, B. Hyman, M. Frosch, 2016, Journal of neuropathology and experimental neurology.

Opposing Roles of apolipoprotein E in aging and neurodegeneration

Rosemary J. Jackson, B. Hyman, T. Spires-Jones, 2019, Life Science Alliance.

Patient-Level Factors Associated with Oncology Provider-Delivered Brief Tobacco Treatment Among Recently Diagnosed Cancer Patients

A. Muzikansky, C. Ponzani, E. Friedman, 2020, Tobacco use insights.

Multimodal optical imaging and spectroscopy for the intraoperative mapping of nonmelanoma skin cancer

A. Muzikansky, V. Neel, A. Yaroslavsky, 2009 .

Validating Techniques for Measurement of Cutaneous Neurofibromas

A. Muzikansky, J. Blakeley, S. Plotkin, 2021, Neurology.

Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes

A. Hauschild, M. Mihm, S. Hirakawa, 2005, Modern Pathology.

Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.

Michael Detmar, Alona Muzikansky, Claus Garbe, 2003, The American journal of pathology.

Abstract CT046: Phase I dose escalation study of the CDK4/6 inhibitor palbociclib in combination with the MEK inhibitor PD-0325901 in patients withRASmutant solid tumors

C. Paweletz, P. Jänne, Kwok-Kin Wong, 2017 .

Identification of the novel activity-driven interaction between synaptotagmin 1 and presenilin 1 links calcium, synapse, and amyloid beta

B. Hyman, M. Arimon, O. Berezovska, 2016, BMC Biology.

Phase II Study of Protracted Daily Temozolomide for Low-Grade Gliomas in Adults

P. Wen, K. Ligon, P. Black, 2008, Clinical Cancer Research.

The Outcome of Surgical Resection Versus Assignment to the Liver Transplant Waiting List for Hepatocellular Carcinoma

A. Muzikansky, J. Pierie, K. Tanabe, 2005, Annals of Surgical Oncology.

EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes.

M. Mino‐Kenudson, J. Neal, H. Wakelee, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer’s disease

M. Garcia-Alloza, B. Bacskai, A. Muzikansky, 2020, Nature Communications.

Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages

R. Jain, D. Fukumura, M. Snuderl, 2016, Proceedings of the National Academy of Sciences.

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma

Radleigh G. Santos, P. Wen, W. Curry, 2019, Clinical Cancer Research.

Diaphragm Training in Amyotrophic Lateral Sclerosis

S. Loring, A. Muzikansky, K. Hembre, 2008, Journal of clinical neuromuscular disease.

A phase II trial of the cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non-small cell lung cancer.

B. Rollins, T. Lynch, G. Shapiro, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

A Phase II Trial of the Cyclin-dependent Kinase Inhibitor Flavopiridol in Patients with Previously Untreated Stage IV Non-Small Cell Lung Cancer 1

B. Rollins, T. Lynch, G. Shapiro, 2001 .

Bone marrow response as a potential biomarker of outcomes in glioblastoma patients.

B. Nahed, A. Muzikansky, A. Fathi, 2017, Journal of neurosurgery.

Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma

Katrina H. Smith, P. Wen, R. Jain, 2018, Clinical Cancer Research.

Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease.

J. Growdon, B. Hyman, M. Frosch, 2013, Journal of neuropathology and experimental neurology.

Quantitative Assessment of Whole-Body Tumor Burden in Adult Patients with Neurofibromatosis

M. Askenazi, L. Munn, W. Cai, 2012, PloS one.

Examining perceived cancer risk among patients with neurofibromatosis type 1

A. Muzikansky, E. Park, A. Vranceanu, 2015, Journal of Neuro-Oncology.

Ten-Year Follow-up of Internal Neurofibroma Growth Behavior in Adult Patients With Neurofibromatosis Type 1 Using Whole-Body MRI

A. Muzikansky, M. Bredella, S. Plotkin, 2022, Neurology.

Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival

Jennie W. Taylor, Jonathan W. Song, R. Jain, 2016, Proceedings of the National Academy of Sciences.

Phase 2 study of dose-intense temozolomide in recurrent glioblastoma.

Katrina H. Smith, R. Beroukhim, P. Wen, 2013, Neuro-oncology.

Outcomes of preimplantation genetic diagnosis in neurofibromatosis type 1.

A. Muzikansky, M. Hughes, T. Murphy, 2015, Fertility and sterility.

Uptake of BRCA1 rearrangement panel testing: In individuals previously tested for BRCA1/2 mutations

A. Muzikansky, K. Niendorf, P. Ryan, 2006, Genetics in Medicine.

Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphoma.

A. LaCasce, T. Batchelor, A. Muzikansky, 2012, Biology of Blood and Marrow Transplantation.

Cytologic features of endocervical glandular lesions: Comparison of SurePath, ThinPrep, and conventional smear specimen preparations

D. Wilbur, A. Muzikansky, J. Misdraji, 2008, Diagnostic cytopathology.

Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein.

S. Maheswaran, A. Muzikansky, P. Walden, 2006, Cancer research.

Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome

A. Muzikansky, E. Park, S. Plotkin, 2012, Genetics in Medicine.

Cell release during perfusion reflects cold ischemic injury in rat livers

M. Toner, S. Stott, J. Markmann, 2020, Scientific Reports.

Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.

T. Fujii, D. Finkelstein, R. Chung, 2008, JAMA.

Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas.

P. Black, A. Chakravarti, J. Loeffler, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Acquired Resistance to First‐Line Afatinib and the Challenges of Prearranged Progression Biopsies

L. Sequist, J. Engelman, P. Fidias, 2016, Journal of Thoracic Oncology.

Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses

P. Jänne, D. Haber, L. Sequist, 2015, Clinical Cancer Research.

Bevacizumab for recurrent malignant gliomas

P. Wen, S. Kesari, A. Norden, 2008, Neurology.

Programmed Cell Death Ligand (PD‐L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases

M. Mino‐Kenudson, E. Mark, J. Engelman, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab.

P. Wen, S. Kesari, A. Norden, 2009, Neuro-oncology.

BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors.

S. Digumarthy, M. Rivera, R. Jain, 2011, Cancer discovery.

Response to treatment and survival of patients with non-small cell lung cancer undergoing somatic EGFR mutation testing.

Alona Muzikansky, Matthew Meyerson, Thomas J Lynch, 2007, The oncologist.

Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models

R. Jain, A. Stemmer-Rachamimov, A. Muzikansky, 2018, Proceedings of the National Academy of Sciences.

The clinical utility of liposomal doxorubicin in recurrent ovarian cancer.

R. Berkowitz, A. Muzikansky, U. Matulonis, 2001, Gynecologic oncology.

Activity of PD-1 blockade with Nivolumab among patients with recurrent atypical/anaplastic meningioma: Phase II trial results.

Raymond Y Huang, R. Beroukhim, P. Wen, 2021, Neuro-oncology.

A Phase I Study of Erlotinib and Hydroxychloroquine in Advanced Non–Small-Cell Lung Cancer

S. Digumarthy, J. Neal, L. Sequist, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Integrating tobacco treatment into cancer care: Study protocol for a randomized controlled comparative effectiveness trial.

N. Rigotti, D. Levy, J. Ostroff, 2016, Contemporary clinical trials.

High-Content Biopsies Facilitate Molecular Analyses and Do Not Increase Complication Rates in Patients With Advanced Solid Tumors.

R. Weissleder, M. Mino‐Kenudson, J. Engelman, 2017, JCO precision oncology.

Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor.

S. Digumarthy, A. Iafrate, M. Mino‐Kenudson, 2015, Cancer discovery.

Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

P. Wen, R. Jain, J. D. de Groot, 2020, Clinical Cancer Research.

Melanoma in the young: Differences and similarities with adult melanoma

M. Mihm, A. Sober, F. Haluska, 2007, Cancer.

Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study.

Jeffrey W. Clark, D. Sahani, J. Meyerhardt, 2010, The Lancet. Oncology.

Elevation of Urinary 2-Hydroxyglutarate in IDH-Mutant Glioma.

A. Iafrate, D. Cahill, B. Nahed, 2016, The oncologist.

Efficacy, Safety, Pharmacokinetics, and Biomarkers of Cediranib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study

D. Sahani, J. Meyerhardt, R. Jain, 2013, Clinical Cancer Research.

Biology of desmoplastic melanoma: a case-control comparison with other melanomas.

M. Mihm, T. Flotte, A. Sober, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcomes and patterns of care in adult skull base chordomas from the Surveillance, Epidemiology, and End Results (SEER) database

W. Curry, H. Shih, A. Muzikansky, 2014, Journal of Clinical Neuroscience.

Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS Tumors.

Alona Muzikansky, Patrick Y Wen, M. Prados, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy

Eric E. Smith, S. Greenberg, J. Wisco, 2005, Annals of neurology.

EMR for Barrett's esophagus-related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy.

D. Park, M. Mino‐Kenudson, A. Muzikansky, 2007, Gastrointestinal endoscopy.

Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma.

Katrina H. Smith, R. Beroukhim, P. Wen, 2015, Neuro-oncology.

Bevacizumab for recurrent malignant gliomas toxicity, and patterns of recurrence

P. Wen, S. Kesari, A. Norden, 2008 .

Phase II trial of sequential chemotherapy followed by chemoradiation, surgery, and postoperative chemotherapy for the treatment of stage IIIA/IIIB non-small-cell lung cancer.

S. Ou, B. Halmos, A. Muzikansky, 2006, Clinical lung cancer.

Prognosis and management of extramammary Paget's disease and the association with secondary malignancies.

D. Finkelstein, A. Muzikansky, J. Pierie, 2003, Journal of the American College of Surgeons.

Phase IB Study of Osimertinib in Combination with Navitoclax in EGFR-mutant NSCLC Following Resistance to Initial EGFR Therapy (ETCTN 9903)

C. Paweletz, P. Jänne, G. Shapiro, 2020, Clinical Cancer Research.

Activity of the Hsp90 inhibitor luminespib among non-small-cell lung cancers harboring EGFR exon 20 insertions

C. Azzoli, L. Sequist, A. Shaw, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Chemotherapy with Erlotinib or chemotherapy alone in advanced non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitors.

S. Digumarthy, L. Sequist, D. Jackman, 2013, The oncologist.

Phase II trial of ponatinib in patients with bevacizumab‐refractory glioblastoma

R. Beroukhim, P. Wen, K. Ligon, 2019, Cancer medicine.

Cetuximab Monotherapy in Patients with Advanced Non-small Cell Lung Cancer After Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy

J. Neal, L. Sequist, P. Fidias, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Outcomes after combined modality therapy for EGFR-mutant and wild-type locally advanced NSCLC.

R. Mak, J. Neal, L. Sequist, 2011, The oncologist.

Role of 18F-fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer.

S. Digumarthy, R. Mak, L. Sequist, 2011, The oncologist.

Natural History of Vestibular Schwannoma Growth and Hearing Decline in Newly Diagnosed Neurofibromatosis Type 2 Patients

A. Muzikansky, S. Plotkin, F. Barker, 2014, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

Validating Techniques for Measurement of Cutaneous Neurofibromas

R. R. Anderson, A. Muzikansky, J. Blakeley, 2021, Neurology.

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma

Katrina H. Smith, R. Beroukhim, P. Wen, 2015, Neurology.

Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer.

Tayyaba Hasan, Brian W Pogue, Conor L Evans, 2010, Cancer research.

The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria

M. Mehta, P. Wen, L. Deangelis, 2014, Neuro-oncology.

Phase II study: integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients.

J. Temel, T. Lynch, S. Block, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase 2 and biomarker study of trebananib, an angiopoietin‐blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma

P. Wen, R. Jain, T. Cloughesy, 2018, Cancer.

Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.

Tracy T Batchelor, Alona Muzikansky, Santosh Kesari, 2007, Neuro-oncology.

The diagnostic utility of immunohistochemistry in distinguishing primary skin adnexal carcinomas from metastatic adenocarcinoma to skin: an immunohistochemical reappraisal using cytokeratin 15, nestin, p63, D2-40, and calretinin

M. Mahalingam, A. Muzikansky, M. Hoang, 2010, Modern Pathology.

Lymphatic invasion predicts sentinel lymph node metastasis and adverse outcome in primary cutaneous melanoma

S. Kraft, A. Muzikansky, M. Mochel, 2017, Journal of cutaneous pathology.

Sessile Serrated Adenoma: Challenging Discrimination From Other Serrated Colonic Polyps

Mari Mino-Kenudson, Amitabh Srivastava, Alona Muzikansky, 2008, The American journal of surgical pathology.

Increased NY-ESO-1 Expression and Reduced Infiltrating CD3+ T Cells in Cutaneous Melanoma

A. Muzikansky, L. Duncan, P. Giavina-Bianchi, 2015, Journal of immunology research.

Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.

L. Devy, R. Jain, Y. Boucher, 2015, Journal of the National Cancer Institute.

Effects of Early Integrated Palliative Care in Patients With Lung and GI Cancer: A Randomized Clinical Trial.

M. Kamdar, J. Temel, D. Ryan, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma.

Alona Muzikansky, Keith Stuart, Jeffrey W. Clark, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Distribution of Microscopic Melanoma Metastases in Sentinel Lymph Nodes: Implications for Pathology Protocols

A. Sober, A. Muzikansky, A. Cosimi, 2012, The American journal of surgical pathology.

Defining Treatment‐Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment‐Induced Necrosis

H. Shih, M. Bussière, J. Loeffler, 2020, The oncologist.

Tau pathology does not affect experience-driven single-neuron and network-wide Arc/Arg3.1 responses

B. Hyman, T. Spires-Jones, K. Kuchibhotla, 2014, Acta neuropathologica communications.

Co-Targeting IL-6 and EGFR signaling for the treatment of schwannomatosis and associated pain

John W. Chen, A. Stemmer-Rachamimov, A. Muzikansky, 2023, bioRxiv.

High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience

J. Neal, H. Wakelee, L. Sequist, 2022, JTO clinical and research reports.

An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma

P. Wen, S. Kesari, A. Norden, 2009, Journal of Neuro-Oncology.

A Phase II Trial of Vinorelbine in Patients with Advanced Gastroesophageal Adenocarcinoma

Jeffrey W. Clark, P. Fidias, C. Fuchs, 2006, Cancer investigation.

Fluorescence Polarization Imaging of Methylene Blue Facilitates Quantitative Detection of Thyroid Cancer in Single Cells

A. Fischer, A. Muzikansky, A. Yaroslavsky, 2022, Cancers.

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high‐risk patients with diffuse large B‐cell lymphoma

P. Hammerman, M. Hellmann, A. Muzikansky, 2010, Cancer.

Randomized Trial of a Smartphone Mobile App to Improve Symptoms and Adherence to Oral Therapy for Cancer.

Alona Muzikansky, J. Temel, A. Muzikansky, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

Effects of Early Integrated Palliative Care on Caregivers of Patients with Lung and Gastrointestinal Cancer: A Randomized Clinical Trial

M. Kamdar, J. Temel, A. Muzikansky, 2017, The oncologist.

The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.

L. Sequist, D. Dias-Santagata, R. Heist, 2013, The Annals of thoracic surgery.

Perceptions of health status and survival in patients with metastatic lung cancer.

H. Prigerson, J. Temel, A. Muzikansky, 2014, Journal of pain and symptom management.

Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma

Jeffrey W. Clark, J. Meyerhardt, A. Zhu, 2007, Cancer.

Re: Selective Inhibition of Her2-positive Breast Cancer Cells by the Hiv Protease Inhibitor Nelfinavir Notes Erratum: " Comparing Survival of a Sample to That of a Standard Population "

Alona Muzikansky, Dianne M Finkelstein, David A Schoenfeld, 2022 .

The Prognostic Impact of KRAS, Its Codon and Amino Acid Specific Mutations, on Survival in Resected Stage I Lung Adenocarcinoma

A. Iafrate, C. Azzoli, Haiyu Zhou, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Comparison of 4 Acute Pulmonary Embolism Mortality Risk Scores in Patients Evaluated by Pulmonary Embolism Response Teams

A. Muzikansky, D. Courtney, V. Tapson, 2020, JAMA network open.

Computed Tomography Imaging Characteristics of Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements: A Systematic Review and Meta-Analysis.

S. Digumarthy, A. Shaw, J. Shepard, 2019, Clinical lung cancer.

An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma

D. Weitz, K. Isselbacher, D. Haber, 2017, Proceedings of the National Academy of Sciences.

Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: A Randomized Clinical Trial.

N. Rigotti, D. Levy, J. Temel, 2020, JAMA.

Impaired memory is more closely associated with brain beta-amyloid than leukoaraiosis in hypertensive patients with cognitive symptoms

Keith A. Johnson, Eric E. Smith, B. Dickerson, 2018, PloS one.

Occult nipple involvement in breast cancer: clinicopathologic findings in 316 consecutive mastectomy specimens.

Barbara L. Smith, A. Muzikansky, J. Michaelson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized Trial of a Tailored Cognitive-Behavioral Therapy Mobile Application for Anxiety in Patients with Incurable Cancer.

F. Penedo, L. Traeger, J. Temel, 2019, The oncologist.

Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas

Katrina H. Smith, P. Wen, K. Ligon, 2014, Journal of Neuro-Oncology.

Recurrent high-grade glioma treated with bevacizumab: prognostic value of MGMT methylation, EGFR status and pretreatment MRI in determining response and survival

Raymond Y Huang, P. Wen, A. Norden, 2013, Journal of Neuro-Oncology.

Demographic, risk factor, and knowledge differences between Latinas and non-Latinas referred to colposcopy.

C. Verrill, A. Muzikansky, N. Horowitz, 2007, Gynecologic oncology.

Cancer esearch apeutics , Targets , and Chemical Biology ergistic Enhancement of Carboplatin Efficacy with todynamic Therapy in a Three-Dimensional Model for R rometastatic Ovarian

Rizvi, B. Pogue, T. Hasan, 2010 .

Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis

Jeffrey W. Clark, A. Zhu, D. Ryan, 2009, Journal of hematology & oncology.

A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients

Katrina H. Smith, T. Mikkelsen, R. Beroukhim, 2015, Clinical Cancer Research.

Plasma S100β is not a useful biomarker for tumor burden in neurofibromatosis.

W. Cai, G. Harris, A. Muzikansky, 2013, Clinical biochemistry.

Eosinophil and lymphocyte counts predict bevacizumab response and survival in recurrent glioblastoma

B. Nahed, A. Muzikansky, J. Dietrich, 2020, Neuro-oncology advances.

A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma

Jeffrey W. Clark, R. Jain, A. Kambadakone, 2018, Clinical Cancer Research.

Early molecular oxidative stress biomarkers of ischemic penumbra in acute stroke

K. Furie, O. Wu, K. Arai, 2019, Neurology.

Understanding barriers to cervical cancer screening among Hispanic women.

A. Muzikansky, J. Rauh-Hain, M. D. del Carmen, 2009, American journal of obstetrics and gynecology.

Fluorescence Polarization of Methylene Blue as a Quantitative Marker of Breast Cancer at the Cellular Level

Michael R. Hamblin, Anna N. Yaroslavsky, Michael R Hamblin, 2019, Scientific Reports.

SNaPshot genotyping of non-small cell lung cancers (NSCLC) in clinical practice.

A. Iafrate, M. Mino‐Kenudson, L. Sequist, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma

B. Rosen, Jayashree Kalpathy-Cramer, P. Wen, 2017, Journal of Neuro-Oncology.

Intravenous thrombolysis in unwitnessed stroke onset: MR WITNESS trial results

S. Warach, W. Copen, L. Schwamm, 2018, Annals of neurology.

Losartan prevents tumor-induced hearing loss and augments radiation efficacy in NF2 schwannoma rodent models

R. Jain, A. Stemmer-Rachamimov, A. Muzikansky, 2021, Science Translational Medicine.

Association between PIK3CA mutation status and development of brain metastases in HR+/HER2- metastatic breast cancer

A. Iafrate, P. Brastianos, A. Bardia, 2019, Annals of Oncology.

HPV vaccine: A comparison of attitudes and behavioral perspectives between Latino and non-Latino women.

A. Muzikansky, W. Growdon, J. Rauh-Hain, 2009, Gynecologic oncology.

Effect of early palliative care (PC) on quality of life (QOL), aggressive care at the end-of-life (EOL), and survival in stage IV NSCLC patients: Results of a phase III randomized trial.

J. Temel, T. Lynch, A. Muzikansky, 2010 .

Activity of AUY922 in NSCLC patients with EGFR exon 20 insertions.

L. Sequist, J. Engelman, A. Shaw, 2015 .

Behavioral deficits, early gliosis, dysmyelination and synaptic dysfunction in a mouse model of mucolipidosis IV

R. J. Kelleher, B. Hyman, B. Bacskai, 2014, Acta neuropathologica communications.

Retinal Dystrophy and Optic Nerve Pathology in the Mouse Model of Mucolipidosis IV.

R. Betensky, A. Muzikansky, S. Slaugenhaupt, 2016, The American journal of pathology.

Patient-Reported Receipt of Oncology Clinician-Delivered Brief Tobacco Treatment (5As) Six Months following Cancer Diagnosis

J. Ostroff, A. Muzikansky, E. Park, 2023, Oncology.

A phase I study of MLN0128 and bevacizumab in patients with recurrent glioblastoma and other solid tumors.

R. Beroukhim, P. Wen, Helen X. Chen, 2016 .

Problems in the reproducibility of classification of small lung adenocarcinoma: an international interobserver study

A. Yoshizawa, M. Mino‐Kenudson, A. Moreira, 2019, Histopathology.

Examining the effects of problematic alcohol use on cigarette abstinence in recently diagnosed cancer patients enrolled in a cessation trial: A secondary analysis.

N. Rigotti, J. Ostroff, A. Muzikansky, 2020, Addictive behaviors.

Fluorescence Polarization of Methylene Blue as a Quantitative Marker of Breast Cancer at the Cellular Level

Michael R Hamblin, A. Muzikansky, A. Yaroslavsky, 2019, Scientific Reports.

Role of Patient Coping Strategies in Understanding the Effects of Early Palliative Care on Quality of Life and Mood.

J. Temel, A. Muzikansky, E. Park, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model.

P. Donahoe, S. Maheswaran, J. Green, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease.

D. Rimm, A. Muzikansky, A. Mercurio, 2005, Cancer research.

NEURO/MEDICAL ONCOLOGY

Scott N. Hwang, Katrina H. Smith, Susan M. Chang, 2013 .

Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non–small cell lung cancer

P. Wen, L. Deangelis, R. Govindan, 2015, Cancer.

A phase II study of epirubicin and thalidomide in unresectable or metastatic hepatocellular carcinoma.

Jeffrey W. Clark, C. Fuchs, A. Zhu, 2005, The oncologist.

Randomized trial of a smartphone mobile app for adherence to oral chemotherapy.

J. Temel, A. Muzikansky, Jamie M. Jacobs, 2017 .

Translational Potential of Fluorescence Polarization for Breast Cancer Cytopathology

A. Muzikansky, A. Yaroslavsky, Peter R. Jermain, 2023, Cancers.

The effect of surgery and grade on outcome of gastrointestinal stromal tumors.

B. Yeap, W. Souba, A. Muzikansky, 2001, Archives of surgery.

Right‐to‐left ventricular ratio is higher in systole than diastole in patients with acute pulmonary embolism

A. Muzikansky, J. Nielsen-Kudsk, C. Kabrhel, 2023, Echocardiography.

Imaging enabled platforms for development of therapeutics

Brian W. Pogue, Tayyaba Hasan, Conor L. Evans, 2011, BiOS.

Non-small Cell Lung Cancer in Octogenarians: Treatment Practices and Preferences

L. Sequist, P. Fidias, A. Muzikansky, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Early integrated palliative care to improve family caregivers (FC) outcomes for patients with gastrointestinal and lung cancer.

M. Kamdar, J. Temel, D. Ryan, 2016 .

A new BATTLE in the evolving war on cancer.

L. Sequist, J. Engelman, A. Muzikansky, 2011, Cancer discovery.

Role of 18F-fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer.

S. Digumarthy, R. Mak, L. Sequist, 2011, The oncologist.

NCMP-22. TREATMENT-RELATED ADVERSE EFFECTS IN PATIENTS WITH MALIGNANT GLIOMA: ESTABLISHMENT OF KEY FEATURES FOR PSEUDOPROGRESSION AND TREATMENT-INDUCED NECROSIS.

H. Shih, M. Bussière, A. Muzikansky, 2018, Neuro-Oncology.

Cell release during perfusion reflects cold ischemic injury in rat livers

M. Toner, S. Stott, J. Markmann, 2020, Scientific Reports.

Losartan rewires ovarian cancer tumor-immune microenvironment and suppresses IGF-1 to amplify chemo-immunotherapy sensitivity

A. Muzikansky, S. Subudhi, Yao Sun, 2023, bioRxiv.

A. Muzikansky, A. Vranceanu, S. Plotkin, 2016, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

Role of 18F-fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer.

S. Digumarthy, R. Mak, L. Sequist, 2011 .

Abstract CT232: Phase I combination study of the CHK1 inhibitor prexasertib (LY2606368) and olaparib in patients with high-grade serous ovarian cancer and other advanced solid tumors

G. Shapiro, A. D’Andrea, A. Muzikansky, 2019, Clinical Trials.

A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy.

Katrina H. Smith, P. Wen, E. Wong, 2014, Neuro-oncology.

Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2

A. Stemmer-Rachamimov, M. Giovannini, A. Muzikansky, 2023, Neuro-oncology advances.

A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumors.

A. Muzikansky, U. Matulonis, M. Seiden, 2005, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumors

A. Muzikansky, U. Matulonis, M. Seiden, 2004, International Journal of Gynecologic Cancer.

Opposing Roles of apolipoprotein E in aging and neurodegeneration

Rosemary J. Jackson, B. Hyman, T. Spires-Jones, 2019, Life Science Alliance.

BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors.

S. Digumarthy, M. Rivera, R. Jain, 2011, Cancer discovery.

Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer

Manish B. Patel, A. Iafrate, A. Drilon, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

End-of-Life Care in Patients with Metastatic Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations.

L. Sequist, R. Heist, J. Temel, 2016, Journal of palliative medicine.

Safety of osimertinib plus chemotherapy in EGFR-mutant NSCLC.

L. Sequist, A. Shaw, R. Heist, 2018 .

Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults.

P. Wen, K. Ligon, P. Black, 2008, Neuro-oncology.

An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma

D. Weitz, K. Isselbacher, D. Haber, 2017, Proceedings of the National Academy of Sciences.

Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.

Eric E. Smith, M. Albert, R. Killiany, 2008, Archives of neurology.

FP01.05 The ASCENT Trial: A Phase II Study of Neoadjuvant/Adjuvant Afatinib, Chemoradiation +/- Surgery for Stage III EGFR-Mutant NSCLC

P. Jänne, R. Mak, M. Mino‐Kenudson, 2021 .